Table 1 summarizes recent key studies establishing conventional MRI metrics as valid outcome ... Relapsing–remitting multiple sclerosis. BPF: Brain parenchymal fraction; CIS: Clinically isolated ...

MRI is a diagnostic test that doctors use to diagnose and track the progress of amyotrophic lateral sclerosis (ALS). ALS is a progressive disease that damages nerve cells in the brain and spinal cord.

The FDA cleared an extended version of Neurophet AQUA that uses AI for analysis in counting and measuring MS brain lesions on ...

Explore how childhood social disadvantages, like poverty and limited healthcare access, impact the severity of multiple ...

Brain volume can transiently increase ... grants or patents received or pending, or royalties. MRI is a key modality for assessing multiple sclerosis (MS) disease course and response to treatment.

Neurophet AQUA analyzes MRI (magnetic resonance images) with AI technology to analyze brain atrophy and WMH observed in ...

The Center for Multiple Sclerosis and Autoimmune Neurology at Mayo Clinic works across the continuum of research, education and practice so each person gets the care they need.

A relatively easy way to encourage your Black patients with MS to participate in clinical research is to introduce them to ...

November 25, 2024icometrix’ FDA-cleared quantitative brain solution for neurological conditions including Alzheimer’s and multiple sclerosis is ...

Royal Philips (PHG) and icometrix have teamed up to deploy an AI-driven, end-to-end solution for acquiring, reading, and reporting the results ...